Results

Total Results: 1,628 records

Showing results for "determining".

1321. Research Protocol: Care Interventions for PeopleWith Dementia (PWD) and Their Caregivers (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/pwd-care-interventions-protocol.pdf
      February 22, 2019 - Research Protocol: Care Interventions for PeopleWith Dementia (PWD) and Their Caregivers Evidence-based Practice Center Systematic Review Protocol Project Title: Care Interventions for People With Dementia (PWD) and their Caregivers I. Background and Objectives for the Systematic Review Rising rates of de…

1322. PowerPoint Presentation (ppt file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-options-summarizing.ppt
      June 01, 2012 - PowerPoint Presentation Options for Summarizing Medical Test Performance in the Absence of a “Gold Standard” Prepared for: The Agency for Healthcare Research and Quality (AHRQ) Training Modules for Medical Test Reviews Methods Guide www.ahrq.gov Options for Summarizing Medical Test Performance in the Absence of a …

1323. Disposition of Comments Report for Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
      September 25, 2013 - We have already extracted information on the methods for determining cut-offs for reactivity in each … concluding statement also be included: “Currently, platelet function testing may be considered in determining

1324. Ahrq Community Forum Webinar Branson (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/ahrq_community_forum_webinar_branson.pdf
      October 13, 2011 - <#> Significant Work. Extraordinary People. SRA. Outreach to Patient and Consumer Representatives October 13, 2011 Carolyn Branson, Manager Consumer Reviewer Administration 2 Topics • Who are they? • What characteristics do they share? • How can you identify the “right” perso…

1325. Bar-Cohen_ ECCS2012 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/bar-cohen_-eccs2012.pdf
      January 01, 2012 - Bar-Cohen_ ECCS2012 Slide 1: Addressing  Tensions  When Social/Family Support and Evidence-­‐ Based Care Collide Annette Bar-­‐Cohen, M.A., M.P.H., Discussant Executive Director, Center for NBCC Advocacy Training National Breast Cancer  Coalition,  Washington,  DC …

1326. Hypertension-Pulmonary-Arterial Research-Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypertension-pulmonary-arterial_research-protocol.pdf
      January 30, 2013 - blockers.4 After PAH is confirmed by right heart catheterization, the diagnostic workup turns to determining … eligibility criteria for inclusion in this review, as well as demographic and other data needed for determining

1327. Pharmacologic and Non-pharmacologic Therapies in Adult Patients with Acute Exacerbation of COPD: A Systematic Review (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/copd-research-protocol.pdf
      April 11, 2018 - antibiotics), modes of application and durations of treatment needs to be established.37-40 In summary, determining … A systematic review of current evidence will assist clinicians in understanding and determining optimal

1328. Community Forum Deliberative Methods Demonstration: Evaluating Effectiveness and Eliciting Public Views on Use of Evidence--Executive Summary (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/deliberative-methods-demonstration-executive-131125.pdf
      November 01, 2013 - by providers, personal convenience, or concern about out-of-pocket cost—were also instrumental in determining … • Participants noted the difficulties in determining the costs of health care and said that more

1329. Disposition of Comments Report for Procalcitonin-Guides Antibiotic Therapy (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer78_procalcitonin_disposition_20121210.pdf
      October 05, 2012 - The sentence is referring to how this CER will serve as a roadmap for determining future research needs … authors correctly note issues with non-inferiority margins and appropriately note that definitively determining

1330. Disabilities-Quality-Improvement-Outcomes Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/disabilities-quality-improvement-outcomes_executive.pdf
      October 01, 2012 - Determining relevant outcomes and the best way to approach disability depends on how disability is defined … different implications for treatment and coordination within the medical care system, as well as for determining

1331. EPC-Pilot-Project-A-Dual-Approach-To-Facilitate-Health-Systems-Uptake-Of-Evidence-Synthesis-Reports-Anxiety-In-Children (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-anxiety-children_0.pdf
      October 01, 2018 - to the EPC program, although may be considered by EPCs along with other scientific research when determining

1332. Renal Artery Stenosis Management Strategies: An Updated Comparative Effectiveness Review (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-update_disposition-comments.pdf
      August 16, 2016 - pre-clinical and clinical studies that have shown the importance of measuring pressure gradients in determining … pre-clinical and clinical studies that have shown the importance of measuring pressure gradients in determining

1333. Wheelchair-Service Research-Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/wheelchair-service_research-protocol.pdf
      July 01, 2010 - payers (including Medicare, Medicaid, Veterans Affairs, and others) take into consideration when determining

1334. Layout 1 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
      January 01, 2007 - Evaluating the durability of effects on proximal outcomes will be helpful in determining the clinical

1335. Ankyloglossia-protocol-140630 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/ankyloglossia_research-protocol.pdf
      June 30, 2014 - findings reported in the included literature to the general population of children with ankyloglossia by determining

1336. Physiologic Predictors of the Need for Trauma Center Care: A Systematic Review (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/predictors-trauma-care_research-protocol.pdf
      May 31, 2017 - www.effectivehealthcare.ahrq.gov Published online: February 1, 2017, Amended May 31, 2017 4 Determining

1337. Alcohol-Misuse Research-Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse_research-protocol.pdf
      April 28, 2010 - Applying clinical significance methodology to alcoholism treatment trials: determining recovery outcome

1338. Research Protocol: Diabetes Medications for Adults With Type 2 Diabetes: An Update Focused on Monotherapy and Add-On Therapy to Metformin (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-update-2015_research-protocol.pdf
      January 01, 2015 - b) Assessing the precision of outcome data reporting by determining the number and percent of studies

1339. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-adherence-interventions_research-protocol.pdf
      August 18, 2011 - Evaluation of four methods for determining energy intake in young and older women: comparison with doubly

1340. Glaucoma-Screening Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-screening_executive.pdf
      April 01, 2012 - 1 Comparative Effectiveness Review Number 59 Screening for Glaucoma: Comparative Effectiveness Executive Summary Background Glaucoma is a leading cause of visual impairment and blindness and affects approximately 60.5 million people worldwide.1,2 Although glaucoma may be characterized by optic nerve damage, …